Fundraising Fox

Asterias Biotherapeutics

Menlo Park, US · Founded 2012 · Delaware corporation

Biotech

Founders & leadership

JS
Jane S LebkowskiExecutive
MD
Michael D WestExecutive
KS
Katharine SpinkExecutive
JS
Judith SegallExecutive
PL
Pedro LichtingerExecutive
RW
Robert W PeabodyExecutive

Board

AA
Andrew ArnoBoard director
AK
Alfred KingsleyBoard director
RT
Richard T. LeBuhnBoard director
NR
Natale RicciardiBoard director

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 2 of 3 rounds · 2014–2015

▶$4MraisedFeb 2015 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew ArnoDirector
  • Jane S LebkowskiExecutive Officer
  • Michael D WestExecutive Officer, Director
  • Katharine SpinkExecutive Officer
  • Judith SegallExecutive Officer, Director
  • Pedro LichtingerExecutive Officer, Director
  • Robert W PeabodyExecutive Officer, Director
  • Alfred KingsleyDirector
  • Natale RicciardiDirector
  • Richard T. LeBuhnDirector
Offering amount
$4M
Amount sold
$4M
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.7MofferedJun 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PEDRO LICHTINGERExecutive Officer
  • ROBERT W PEABODYExecutive Officer, Director
  • RICHARD T LeBUHNDirector
  • JUDITH SEGALLDirector
  • ALFRED D KINGSLEYDirector
  • MICHAEL D WESTExecutive Officer, Director
Offering amount
$11.7M
Minimum investment
$1M
Proceeds to insiders
$1.7M
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$936KraisedJun 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROBERT W PEABODYExecutive Officer, Director
  • JUDITH SEGALLDirector
  • PEDRO LICHTINGERExecutive Officer
  • ALFRED D KINGSLEYDirector
  • MICHAEL D WESTExecutive Officer, Director
  • RICHARD T LeBUHNDirector
Offering amount
$3.3M
Amount sold
$936K
Proceeds to insiders
$468K
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Good news from Asterias' CIRM-funded spinal cord injury trial - The Stem Cellarblog.cirm.ca.gov · Jan 2017BioTime Subsidiary Asterias Biotherapeutics Raises $13.0 Million in Equity Financing | Fierce Biotechfiercebiotech.com · Jun 2014

Frequently asked questions

How much funding has Asterias Biotherapeutics raised?
Asterias Biotherapeutics has disclosed $4.9M raised across 2 of its 3 known rounds.
Where is Asterias Biotherapeutics headquartered?
Asterias Biotherapeutics is headquartered in Menlo Park, US.